JP2010100624A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010100624A5 JP2010100624A5 JP2009259497A JP2009259497A JP2010100624A5 JP 2010100624 A5 JP2010100624 A5 JP 2010100624A5 JP 2009259497 A JP2009259497 A JP 2009259497A JP 2009259497 A JP2009259497 A JP 2009259497A JP 2010100624 A5 JP2010100624 A5 JP 2010100624A5
- Authority
- JP
- Japan
- Prior art keywords
- angptl3
- antibody
- medicament
- medicament according
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33242901P | 2001-11-16 | 2001-11-16 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003545797A Division JP5105696B2 (ja) | 2001-11-16 | 2002-11-13 | アンジオポエチン様タンパク質３Ａｎｇｐｔｌ３含有組成物とその使用方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010100624A JP2010100624A (ja) | 2010-05-06 |
| JP2010100624A5 true JP2010100624A5 (enExample) | 2011-02-03 |
Family
ID=23298191
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003545797A Expired - Fee Related JP5105696B2 (ja) | 2001-11-16 | 2002-11-13 | アンジオポエチン様タンパク質３Ａｎｇｐｔｌ３含有組成物とその使用方法 |
| JP2009259497A Pending JP2010100624A (ja) | 2001-11-16 | 2009-11-13 | アンジオポエチン様タンパク質３Ａｎｇｐｔｌ３含有組成物とその使用方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003545797A Expired - Fee Related JP5105696B2 (ja) | 2001-11-16 | 2002-11-13 | アンジオポエチン様タンパク質３Ａｎｇｐｔｌ３含有組成物とその使用方法 |
Country Status (14)
| Country | Link |
|---|---|
| US (3) | US7267819B2 (enExample) |
| EP (1) | EP1451578B1 (enExample) |
| JP (2) | JP5105696B2 (enExample) |
| KR (2) | KR101012904B1 (enExample) |
| CN (2) | CN1615440A (enExample) |
| AU (1) | AU2002348286B2 (enExample) |
| CA (1) | CA2464542C (enExample) |
| ES (1) | ES2429034T3 (enExample) |
| IL (2) | IL161542A0 (enExample) |
| MX (1) | MXPA04004609A (enExample) |
| NO (1) | NO336021B1 (enExample) |
| NZ (1) | NZ532852A (enExample) |
| WO (1) | WO2003044172A2 (enExample) |
| ZA (1) | ZA200403070B (enExample) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050123925A1 (en) | 2002-11-15 | 2005-06-09 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
| EP1451578B1 (en) | 2001-11-16 | 2013-08-21 | Genentech, Inc. | Use of angptl3 antagonists for the treatment of liver diseases |
| AU2004266043B2 (en) * | 2003-08-21 | 2007-09-20 | Duchesnay Inc. | Micronutrient supplement |
| US8604185B2 (en) | 2004-07-20 | 2013-12-10 | Genentech, Inc. | Inhibitors of angiopoietin-like 4 protein, combinations, and their use |
| US7371384B2 (en) * | 2004-07-20 | 2008-05-13 | Genentech, Inc. | Compositions and methods of using angiopoietin-like 4 protein antibody |
| PT1771474E (pt) | 2004-07-20 | 2010-05-03 | Genentech Inc | Inibidores de proteína 4 do tipo angiopoietina, combinações e sua utilização |
| US7807645B2 (en) | 2005-09-23 | 2010-10-05 | The Regents Of The University Of California | Method of treating degenerative disorders of the nervous system by administration of fibrinogen fragment |
| CN101855241B (zh) | 2006-12-08 | 2013-11-06 | 莱克康制药公司 | 针对angptl3的单克隆抗体 |
| WO2009128077A1 (en) * | 2008-04-14 | 2009-10-22 | Hadasit Medical Research Services And Development Ltd. | Stable cell binding chimeric peptides |
| CN101852805B (zh) * | 2009-03-31 | 2015-04-01 | 浙江大学 | Angptl3作为卵巢癌的诊断标记物的用途 |
| PL2453921T3 (pl) | 2009-07-14 | 2015-11-30 | Scripps Research Inst | Różnicowanie mezenchymalnych komórek macierzystych |
| EP2521556B1 (en) | 2010-01-08 | 2018-05-30 | Ionis Pharmaceuticals, Inc. | Modulation of angiopoietin-like 3 expression |
| AU2015200969A1 (en) * | 2010-01-08 | 2015-03-19 | Ionis Pharmaceuticals, Inc. | Modulation of angiopoietin-like 3 expression |
| CA2773101C (en) * | 2010-02-02 | 2018-08-21 | Arizona Board Of Regents | Controlled tunnel gap device for sequencing polymers |
| US20130330752A1 (en) * | 2011-01-29 | 2013-12-12 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| JO3412B1 (ar) | 2011-06-17 | 2019-10-20 | Regeneron Pharma | أجسام مضادة ل angptl3 واستخداماتها |
| CA2862485C (en) * | 2012-01-24 | 2021-05-11 | Inter-K Pty Limited | Peptide agents for cancer therapy |
| UY35368A (es) * | 2013-03-08 | 2014-10-31 | Irm Llc | Péptidos y composiciones para el tratamiento de daño articular |
| US9301971B2 (en) | 2013-03-08 | 2016-04-05 | Novartis Ag | Peptides and compositions for treatment of joint damage |
| CN104062432B (zh) * | 2013-03-22 | 2016-01-20 | 中山大学 | ang2在制备ECTC血管类型肝癌诊断试剂及治疗药物中的应用 |
| PE20152002A1 (es) | 2013-05-01 | 2016-01-21 | Isis Pharmaceuticals Inc | Composiciones y metodos para modular la expresion de ttr y vhb |
| CN105814204B (zh) | 2013-12-24 | 2020-04-28 | Ionis制药公司 | 促血管生成素样3表达的调节 |
| ES2844593T3 (es) | 2014-05-01 | 2021-07-22 | Ionis Pharmaceuticals Inc | Composiciones y procedimientos para modular la expresión de la angiopoyetina de tipo 3 |
| CN105021827B (zh) * | 2015-07-17 | 2016-09-28 | 北京大学第一医院 | 检测血清血管生成素样蛋白2含量的物质在制备检测肝脏炎症和纤维化程度产品中的应用 |
| KR20250078597A (ko) | 2015-11-06 | 2025-06-02 | 아이오니스 파마수티컬즈, 인코포레이티드 | 아포리포프로테인 (a) 발현 조정 |
| CN108779159B (zh) * | 2016-02-04 | 2022-12-30 | 瑞泽恩制药公司 | 具有经改造的angptl8基因的非人动物 |
| KR102456731B1 (ko) | 2016-03-03 | 2022-10-24 | 리제너론 파아마슈티컬스, 인크. | Pcsk9 억제제를 angptl3 억제제와 병용하여 투여함으로써 고지혈증을 갖는 환자를 치료하기 위한 방법 |
| AU2018331383B2 (en) | 2017-09-14 | 2024-12-05 | Arrowhead Pharmaceuticals, Inc. | RNAi agents and compositions for inhibiting expression of angiopoietin-like 3 (ANGPTL3), and methods of use |
| AR116566A1 (es) | 2018-10-03 | 2021-05-19 | Novartis Ag | Administración sostenida de polipéptidos similares a la angiopoyetina 3 |
| WO2020099482A2 (en) * | 2018-11-13 | 2020-05-22 | Lipigon Pharmaceuticals Ab | Angptl 3 oligonucleotides influencing the regulation of the fatty acid metabolism |
| TWI747098B (zh) * | 2018-12-21 | 2021-11-21 | 美商美國禮來大藥廠 | 抗angptl3/8複合物抗體及其使用方法 |
| US12559551B2 (en) | 2019-05-24 | 2026-02-24 | Regeneron Pharmaceuticals, Inc. | Stabilized formulations containing anti-ANGPTL3 antibodies |
| MX2022000094A (es) * | 2019-07-04 | 2022-04-27 | Cadila Healthcare Ltd | Vacuna a base de angptl3 para el tratamiento de enfermedad hepática. |
| CN111122872B (zh) * | 2019-11-20 | 2023-01-20 | 中山大学附属第一医院 | 血管生成素样蛋白7在心力衰竭预后评估中的应用 |
| CN110938144B (zh) * | 2019-11-27 | 2022-07-26 | 复旦大学附属儿科医院 | 一种抗angptl3单克隆抗体及其在制备治疗肾病综合征药物中的用途 |
| US20240141029A1 (en) * | 2021-03-05 | 2024-05-02 | Anji Pharmaceuticals Inc. | Methods and compositions for treating sepsis |
| CN114934021B (zh) * | 2022-04-21 | 2023-08-08 | 复旦大学附属儿科医院 | 一种Angptl3敲除的鼠永生化足细胞系及其应用 |
| CN120254294B (zh) * | 2025-06-05 | 2025-09-09 | 南昌大学第一附属医院 | Angptl3在乙肝相关慢加急性肝衰竭预后中的应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6596850B1 (en) * | 1998-01-30 | 2003-07-22 | Ixsys, Incorporated | Anti-αv3β3 recombinant human antibodies, nucleic acids encoding same |
| CA2252629A1 (en) * | 1997-02-26 | 1998-09-03 | Toray Industries, Inc. | Remedies for hepatitis |
| WO1999058660A1 (en) * | 1998-05-12 | 1999-11-18 | Human Genome Sciences, Inc. | 97 human secreted proteins |
| US5972338A (en) * | 1997-09-19 | 1999-10-26 | Genentech, Inc. | Tie ligands homologues |
| US6030831A (en) * | 1997-09-19 | 2000-02-29 | Genetech, Inc. | Tie ligand homologues |
| WO1999055869A1 (en) * | 1998-04-27 | 1999-11-04 | Zymogenetics, Inc. | Novel polypeptide growth factors and materials and methods for making them |
| WO1999067382A2 (en) * | 1998-06-24 | 1999-12-29 | Compugen Ltd. | Angiopoietin-like growth factor sequences |
| KR20010104373A (ko) * | 1999-03-08 | 2001-11-24 | 제넨테크, 인크. | 혈관신생 및 심혈관형성의 촉진 또는 억제 방법 |
| EP1451578B1 (en) | 2001-11-16 | 2013-08-21 | Genentech, Inc. | Use of angptl3 antagonists for the treatment of liver diseases |
-
2002
- 2002-11-13 EP EP02782310.3A patent/EP1451578B1/en not_active Expired - Lifetime
- 2002-11-13 AU AU2002348286A patent/AU2002348286B2/en not_active Ceased
- 2002-11-13 ES ES02782310T patent/ES2429034T3/es not_active Expired - Lifetime
- 2002-11-13 KR KR1020047007410A patent/KR101012904B1/ko not_active Expired - Fee Related
- 2002-11-13 JP JP2003545797A patent/JP5105696B2/ja not_active Expired - Fee Related
- 2002-11-13 NZ NZ532852A patent/NZ532852A/en not_active IP Right Cessation
- 2002-11-13 CN CNA028271920A patent/CN1615440A/zh active Pending
- 2002-11-13 KR KR1020107004734A patent/KR20100029861A/ko not_active Ceased
- 2002-11-13 MX MXPA04004609A patent/MXPA04004609A/es active IP Right Grant
- 2002-11-13 WO PCT/US2002/036865 patent/WO2003044172A2/en not_active Ceased
- 2002-11-13 CA CA2464542A patent/CA2464542C/en not_active Expired - Fee Related
- 2002-11-13 IL IL16154202A patent/IL161542A0/xx not_active IP Right Cessation
- 2002-11-13 CN CN2010102426068A patent/CN101905024A/zh active Pending
- 2002-11-15 US US10/298,461 patent/US7267819B2/en not_active Expired - Lifetime
-
2004
- 2004-04-22 ZA ZA2004/03070A patent/ZA200403070B/en unknown
- 2004-06-09 NO NO20042410A patent/NO336021B1/no not_active IP Right Cessation
-
2006
- 2006-09-29 US US11/537,567 patent/US20070134250A1/en not_active Abandoned
-
2008
- 2008-05-28 US US12/128,545 patent/US8541376B2/en not_active Expired - Fee Related
-
2009
- 2009-11-13 JP JP2009259497A patent/JP2010100624A/ja active Pending
-
2010
- 2010-02-11 IL IL203894A patent/IL203894A/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010100624A5 (enExample) | ||
| JP2005521643A5 (enExample) | ||
| CN114057869B (zh) | 针对中东呼吸综合征-冠状病毒刺突蛋白的人抗体 | |
| JP2012504602A5 (enExample) | ||
| JP2022031635A5 (enExample) | ||
| JP2017113019A5 (enExample) | ||
| JP2010526028A5 (enExample) | ||
| JP2010502207A5 (enExample) | ||
| JP2017537084A5 (enExample) | ||
| JP2017507652A5 (enExample) | ||
| WO2015107126A1 (en) | Neutralizing human monoclonal antibodies against hepatitis b virus surface antigen | |
| CN108064240A (zh) | 针对流感血凝素的人抗体 | |
| JP2009225799A5 (enExample) | ||
| JP2010524489A5 (enExample) | ||
| JP2017533694A5 (enExample) | ||
| CA2624935A1 (en) | Anti-myostatin antibodies | |
| JP2015503909A5 (enExample) | ||
| JP2015212281A5 (enExample) | ||
| JP2010536384A5 (enExample) | ||
| JP2011505867A5 (enExample) | ||
| JP2011528902A5 (enExample) | ||
| JP2012500020A5 (enExample) | ||
| JP2014515763A5 (enExample) | ||
| JP2017507657A5 (enExample) | ||
| JP2010526076A5 (enExample) |